JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bauer, C.
Right arrow Articles by Eisenhut, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bauer, C.
Right arrow Articles by Eisenhut, M.

131I-Labeled Peptides as Caspase Substrates for Apoptosis Imaging

Claudia Bauer, PhD1, Ulrike Bauder-Wuest1, Walter Mier, PhD2, Uwe Haberkorn, MD2 and Michael Eisenhut, PhD1

1 Department of Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, Germany
2 Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany



View larger version (16K):

[in a new window]
 
FIGURE 1. Time-course development of apoptosis obtained with camptothecin-treated Jurkat cells. (A and B) Flow cytometry using Alexa Fluor 488-labeled annexin V showing phosphatidylserine externalization (A) and formation of fluorescent rhodamine 110 mediated through caspase-3 hydrolysis of Z-DEVD-R110 (B) (n = 3). Data are expressed as mean ± SD. arb. units = arbitrary units.

 


View larger version (29K):

[in a new window]
 
FIGURE 2. Propidium iodide (FL-III)/Alexa Fluor 488-annexin V (FL-I) flow cytometry of Jurkat cells treated with 10 µmol/L camptothecin for 4 h (A) and 1 µmol/L staurosporine for 3 h (B). Q1 = apoptotic cells; Q2 = apoptotic and necrotic cells; Q3 = living cells; Q4 = dead cells.

 


View larger version (15K):

[in a new window]
 
FIGURE 3. Uptake kinetics of 99mTc-HYNIC-annexin V in apoptotic and control cells. Cells showed 62% apoptosis with Alexa Fluor 488-annexin V measured by flow cytometry (n = 3). Data are expressed as mean ± SD.

 


View larger version (16K):

[in a new window]
 
FIGURE 4. Uptake in apoptotic and control cells of 131I-labeled DEVDGY-NH2 (1) and YDEVDG-NH2 (2) (A) as well as NQVNGY-NH2 (3) and YNQVNG-NH2 (4) (B) (n = 3). Data are expressed as mean ± SD.

 


View larger version (32K):

[in a new window]
 
FIGURE 5. Uptake in apoptotic and control cells of yDEVDG-conjugated Tat sequences (5–10) (n = 3). Data are expressed as mean ± SD.

 


View larger version (19K):

[in a new window]
 
FIGURE 6. Rhodamine 110 formation through caspase-mediated hydrolysis of Z-DEVD-R110 with increasing amounts of peptides 2 and 7 (n = 3). Data are expressed as mean ± SD.

 


View larger version (18K):

[in a new window]
 
FIGURE 7. MALDI mass spectra of peptide 7 incubated with (A) and without (B) commercial caspase-3 (m/z represents molecular mass/charge).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.